Niro Ramachandran Ph.D.
Net Worth

Last updated:

What is Niro Ramachandran Ph.D. net worth?

The estimated net worth of Dr. Niro Ramachandran Ph.D. is at least $1,225,062 as of 15 Feb 2023. He owns shares worth $32,342 as insider and has received compensation worth at least $1,192,720 in Akoya Biosciences, Inc..

What is the salary of Niro Ramachandran Ph.D.?

Dr. Niro Ramachandran Ph.D. salary is $298,180 per year as Chief Bus. Officer in Akoya Biosciences, Inc..

How old is Niro Ramachandran Ph.D.?

Dr. Niro Ramachandran Ph.D. is 50 years old, born in 1975.

What stocks does Niro Ramachandran Ph.D. currently own?

As insider, Dr. Niro Ramachandran Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Akoya Biosciences, Inc. (AKYA) Chief Bus. Officer 25,073 $1.29 $32,342

What does Akoya Biosciences, Inc. do?

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Niro Ramachandran Ph.D. insider trading

Akoya Biosciences, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Employee Stock Option (Right to Buy) 34,000 $0.91 $30,940
Option
Common Stock 34,000 $0.91 $30,940
Option
Employee Stock Option (Right to Buy) 75,107 $0.91 $68,347
Option
Common Stock 75,107 $0.91 $68,347
Purchase
Common Stock 25,000 $13.13 $328,300
Purchase
Common Stock 73 $12.85 $938

Akoya Biosciences key executives

Akoya Biosciences, Inc. executives and other stock owners filed with the SEC: